 |
|
 |
August 26, 2008 |
Now Available:
Watch video podcasts of the 2008 EULAR press conferences
CME Opportunity:
Musculoskeletal Report provides cutting-edge scientific updates through biweekly and special edition newsletters, in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.
Arthritis:
Annals of Internal Medicine Study Says Merck ADVANTAGE Trial Was Marketing Dressed Up as Science
New findings based on internal Merck records disclosed during litigation show that ADVANTAGE (Assessment of Differences between Vioxx and Naproxen To Ascertain Gastrointestinal Tolerability and Effectiveness) was actually a seeding trial designed to support a marketing campaign before Vioxx's launch....
Pain:
Review Discourages Use of Amitriptyline in Fibromyalgia, but May Not Be the Last Word
A review of studies of the tricyclic antidepressant amitriptyline (Elavil) for fibromyalgia was generally discouraging, but questions have been raised about the quality of studies included...
Autoimmunity:
While Olympians Chase Medals, Chicken Collagen Advances as RA Immunotherapy
Inducing oral tolerance with chicken type II collagen (CCII) may help alleviate the signs and symptoms of rheumatoid arthritis (RA) with fewer side effects than methotrexate (MTX), Chinese researchers say...
Consumer News:
After Fits and Starts, New Hope for Psoriasis Patients
Psoriasis patients are finally finding some relief with a new wave of drug treatments known as biologics...
BioPharm Business:
Emisphere Reports Full Recruitment of Study Evaluating Eligen Technology and Salmon Calcitonin on Vertebral Fractures in Postmenopausal Women
Emisphere Technologies announced that recruitment is finished for a randomized, double-blind, placebo-controlled, multicenter study of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D...